Indoloquinolines as Scaffolds for Drug Discovery

Author(s): J. Lavrado, R. Moreira, A. Paulo

Journal Name: Current Medicinal Chemistry

Volume 17 , Issue 22 , 2010


Become EABM
Become Reviewer
Call for Editor

Abstract:

Traditional medicines have contributed greatly over the centuries to the discovery and development of new therapeutic agents and indoloquinoline alkaloids may represent a new class of drug leads. Cryptolepine (5-methyl-5H-indolo[ 3,2-b]quinoline), neocryptolepine (5-methyl-5H-indolo[2,3-b]quinoline), isocryptolepine (5-methyl-5H-indolo[3,2- c]quinoline, extracted from the African medicinal plant Cryptolepis sanguinolenta, and isoneocryptolepine (5-methyl-5H-indolo[ 2,3-c]quinoline), which has never been found in nature, are isomeric tetracyclic compounds of particular interest due to their broad spectrum of biological activities including antiparasitic, antifungal, antibacterial, cytotoxic, antiinflammatory and antihyperglycaemic. As a result, in the last 30 years hundreds of indoloquinoline analogues were synthesized and their biological activities evaluated. In this paper, we present an overview of the potential of indoloquinolines as scaffolds in drug discovery by reviewing the in vitro and in vivo biological activities of natural and synthetic analogues, as well as the proposed mechanisms of action and structure-activity relationships.

Keywords: Indoloquinolines, cryptolepine, isocryptolepine, neocryptolepine, isoneocryptolepine, structure-activity relationships (SAR), Cryptolepis sanguinolenta

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 22
Year: 2010
Page: [2348 - 2370]
Pages: 23
DOI: 10.2174/092986710791698521
Price: $65

Article Metrics

PDF: 33